Differences in disease manifestations, severity, and management require special consideration from rheumatologists who treat children and adolescents with systemic lupus erythematosus
Joint Smart Coalition Takes on Psoriasis in New York City
The Arthritis Foundation and the National Psoriasis Foundation launched the Joint Smart Coalition to focus on patient education, resources, and outreach. At a coalition-sponsored community-outreach event at Queens College in Flushing, N.Y., attendees were provided information on setting goals, stretching techniques, easy exercises, treatment options, and tips for a healthy lifestyle. (posted Dec. 13)
Inflammatory Myopathies Difficult to Diagnose, Treat
Without a single set of diagnostic criteria for identifying polymyositis, dermatomyositis, or myositis and scant evidence-based therapeutic guidelines, these rare muscle diseases can be hard to manage
Is It Time to Reevaluate Your Physician Compensation Model?
Ongoing payment reform, healthcare consolidation forces rheumatology practices to reconsider ways doctors are paid
2013 ACR/ARHP Annual Meeting: Rheumatologists In the Spotlight
ACR members honored with awards for service, research, and mentorship in rheumatology
Paul Davis, MD, Steps Down as Editor-in-Chief of Clinical Rheumatology
Dr. Davis’ eight-year tenure at the international rheumatology journal marked by growth in number of submitted manuscripts, international reach, and global impact
2013 ACR/ARHP Annual Meeting: Rheumatologists Must Prepare for ICD-10 Coding System
How the 10th revision of the International Statistical Classification of Diseases and Health-Related Problems starting in 2014 will impact rheumatology practices, physicians, and staff
2013 ACR/ARHP Annual Meeting: The Rheumatoid Arthritis Treatment Debate
Discussion by rheumatologists on the merits of biologics vs. triple therapy for patients with RA lends insight into therapeutic alternatives
2013 ACR/ARHP Annual Meeting: Rheumatology Year in Review
Progress in treatments for pediatric rheumatic diseases, collaborative clinical trials, and personalized therapeutic approaches highlight the past year in rheumatology
2013 ACR/ARHP Annual Meeting: Advances in Genomic Research Demystify, Defeat Disease
Researcher J. Craig Venter, PhD, explains how technological progress in metabiomics may enable scientists to create synthetic, engineered bacteria to counter diseases and manufacture virus-fighting vaccines where they are needed
- « Previous Page
- 1
- …
- 643
- 644
- 645
- 646
- 647
- …
- 823
- Next Page »